Objective assessment of gait after intrathecal baclofen in hereditary spastic paraplegia [6]

Journal of Neurology

Volumn 252, Issue 8, 2005, Pages 991-993

  Klebe, S ^a   Stolze, H ^a   Kopper, F ^a   Lorenz, D ^a   Wenzelburger, R ^a   Deuschl, Guenther ^a   Volkmann, J ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; SPASMOLYTIC AGENT;

CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GAIT; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LETTER; PHYSIOTHERAPY; PRIORITY JOURNAL;

EID: 23944476197     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-005-0792-1     Document Type: Letter

References (7)

1. Bickerstaff ER (1950) Hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry 13:134-145
2. Sutherland JM (1975) Familial spastic paraplegia Amsterdam. In: Vinken PJBG (ed) Handboock of clinical neurology
3. Klebe S, Stolze H, Volkmann J, et al. (2004) Gait analysis in hereditary spastic paraplegia. J Neurol (in press)
4. Penn RD, Kroin JS (1984) Intrathecal baclofen alleviates spinal cord spasticity (letter). Lancet 1:1078
5. Penn RD (1992) Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77:236-240
6. Penn RD, Savoy SM, Corcos D, et al. (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320:1517-1522
7. Stolze H, Kuhtz-Buschbeck JP, Mondwurf C, et al. (1997) Gait analysis during treadmill and overground locomotion in children and adults. Electroencephalogr Clin Neurophysiol 105(6):490-497